Literature DB >> 9029109

Regulation of class I-restricted epitope processing by local or distal flanking sequence.

A J Yellen-Shaw1, L C Eisenlohr.   

Abstract

Influenza A/Puerto Rico/8/34 nucleoprotein (NP) contains an H-2Kd-restricted CD8+ T cell (T CD8+) epitope spanning amino acid residues 147-155. It was previously demonstrated that expression of NP147-155 and NP147-158 in isolation via "minigene"/recombinant vaccinia virus (vac) technology leads to sensitization of target cells for NP-specific killing while expression of 147-158 lacking the arginine at position 156 (termed here as 147-155TG) does not. The presentation block was overcome by placing this fragment into the context of full length NP. We show that addition of a single amino acid, Met159, to the C terminus of the blocked peptide (creating 147-155TGM) restores presentation. Presentation of 147-155TGM was not due to trimming in the exocytic compartment, consistent with severe limitations on C-terminal trimming activity in this location. Rescued presentation was also achieved when the blocked construct was extended in the N-terminal direction only, but in this case more than 55 amino acids of flanking sequence were required. The transition to presentation was abrupt, with 91-155TG and shorter constructs showing little or no detectable presentation and 90-155TG showing full level presentation. Presentation could not be attributed to acquisition of conventional targets for ubiquitination since mutation of all Lys residues, to which the ubiquitin moiety is conjugated, does not abrogate presentation. Rescued presentation was not inhibited by the peptide aldehyde N-acetyl-L-leucinyl-L-leucinal-L-norleucinal, suggesting that the added elements may be recruiting nonproteasomal activity. We have therefore identified and begun to characterize protease targeting of regulatory elements, both local and distal to an epitope, which strongly influence the ability of the epitope to be excised.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029109

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones.

Authors:  Lawrence M Mylin; Todd D Schell; Melanie Epler; Caroline Kusuma; David Assis; Chelsea Matsko; Alexandra Smith; April Allebach; Satvir S Tevethia
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

2.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

3.  Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide.

Authors:  A Craiu; T Akopian; A Goldberg; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Cutting Edge: Selective role of ubiquitin in MHC class I antigen presentation.

Authors:  Lan Huang; Julie M Marvin; Nia Tatsis; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

5.  Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

Authors:  D Valmori; U Gileadi; C Servis; P R Dunbar; J C Cerottini; P Romero; V Cerundolo; F Lévy
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

6.  Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.

Authors:  Jeffrey R Currier; Mark deSouza; Penprapa Chanbancherd; Wendy Bernstein; Deborah L Birx; Josephine H Cox
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation.

Authors:  Xueying Ma; Amparo Serna; Ren-Huan Xu; Luis J Sigal
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

8.  Portable flanking sequences modulate CTL epitope processing.

Authors:  Sylvie Le Gall; Pamela Stamegna; Bruce D Walker
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes.

Authors:  Isobella Honeyborne; Andrew Prendergast; Florencia Pereyra; Alasdair Leslie; Hayley Crawford; Rebecca Payne; Shabashini Reddy; Karen Bishop; Eshia Moodley; Kriebashnie Nair; Mary van der Stok; Noel McCarthy; Christine M Rousseau; Marylyn Addo; James I Mullins; Christian Brander; Photini Kiepiela; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

10.  Precise identification of a human immunodeficiency virus type 1 antigen processing mutant.

Authors:  Peter Zimbwa; Anita Milicic; John Frater; Thomas J Scriba; Antony Willis; Philip J R Goulder; Tilly Pillay; Huldrych Gunthard; Jonathan N Weber; Hua-Tang Zhang; Rodney E Phillips
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.